Chromosome 9p21 and coronary risk - The mystery continues

Atherosclerosis

Volumn 214, Issue 2, 2011, Pages 257-258

  Linsel Nitschke, Patrick ^a   Schunkert, Heribert ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B;

CHROMOSOME 9P; CORONARY ARTERY DISEASE; CORONARY RISK; GENE LOCUS; HEART INFARCTION; HUMAN; NOTE; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 9; CORONARY ARTERY DISEASE; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; PHENOTYPE; PURINE-NUCLEOSIDE PHOSPHORYLASE; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 79151480544     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.08.059     Document Type: Note

References (14)

1. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 357:443-453.
2. Schunkert H., Gotz A., Braund P., et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008.
3. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
4. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316:1491-1493.
5. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
6. Saxena R., Voight B.F., Lyssenko V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
7. Caldas C., Hahn S.A., da Costa L.T., et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994, 8:27-32.
8. Cannon-Albright L.A., Goldgar D.E., Meyer L.J., et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1992, 258:1080-1081.
9. Zeller T., Wild P., Szymczak S., et al. Genetics and beyond - the transcriptome of human monocytes and disease susceptibility. PLoS One 2010, 5:e10693.
10. Holdt L.M., Beutnr F., Scholz M., et al. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Atheroscler Thromb Vasc Biol 2010, 30:620-627.
11. Holdt L.M., Sass K., Gäbel G., et al. Expression of Chr9p21 genes CDKN2B (p15INK4b), CDKN2A (p16INK4a, p14ARF) and MTAP in human atherosclerotic plaque. Atherosclerosis 2011, 214:264-270.
12. Visel A., Zhu Y., May D., et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010, 464:409-412.
13. Folkersen L., Kyriakou T., Goel A., et al. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One 2009, 4:e7677.
14. Cunnington M.S., Koref M.S., Mayosi B.M., Burn J., Keavney B.D. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with anril expression. PLoS Genet 2010, 6:e1000899.